Robert J. Shovlin has sold NEO and made no open-market buys since Jun 2018

Robert J. Shovlin is a corporate executive in the laboratory and genomics sector and has served as President, Clinical Services at NeoGenomics Inc., a cancer‑focused genetic testing company.( In this role, he led NeoGenomics’ clinical services division, overseeing operations and growth of its diagnostic testing services, and was a reporting officer and corporate insider for the company.( He previously served as NeoGenomics’ Chief Operating Officer (and COO of its NeoGenomics Laboratories subsidiary) beginning in October 2014, with responsibilities spanning operational leadership and business growth initiatives.(

Before joining NeoGenomics, Shovlin built a career leading and developing diagnostics businesses, including serving as Chief Development Officer at Bostwick Laboratories, where he was responsible for sales, marketing, managed care, business development, and clinical trials.( From 2005 to 2011, he held progressively senior roles culminating as President and Chief Executive Officer of Aureon Biosciences, a venture‑backed company focused on proprietary prostate cancer diagnostics.( Earlier, he held executive and sales leadership positions at Quest Diagnostics and Dianon Systems in anatomic pathology and managed care.( Shovlin began his professional career as a Captain and Infantry Officer in the United States Marine Corps, serving as a platoon and company commander and instructor.( He holds a Bachelor of Science degree from Pennsylvania State University and an MBA in Finance (with highest honors) from Rutgers University.(

Written by Perplexity from public sources.